Stimuli-Responsive Nanoparticles for siRNA Delivery
- PMID: 26323434
- DOI: 10.2174/1381612821666150901095349
Stimuli-Responsive Nanoparticles for siRNA Delivery
Abstract
Nanoparticles have been extensively employed to deliver many drugs, including siRNA, for the treatment of a variety of diseases, particularly cancer. Lately, there has been a great deal of effort to design nanoparticles with materials that are able to respond to intrinsic or extrinsic stimuli for "on demand" delivery of siRNA. These nanoparticles are able to trigger siRNA release upon different stimuli, such as a pH decrease, redox gradient, enzyme, light, magnetic field, temperature, ultrasound or electric current. Frequently, the stimuli cause the nanoparticles to undergo protonation, hydrolytic breakdown or phase transition for triggered release of siRNA, resulting in decreased side effects and better therapeutic outcome. While studies have demonstrated efficient in vitro and in vivo delivery, these "smart" nanoparticles have not yet reached the clinic. In this review, we address different classes of nanoparticles, such as polyplexes, lipoplexes, liposomes, polymeric micelles, polymeric, lipid and inorganic nanoparticles, that are able to respond to specific stimuli for siRNA triggered-release, emphasizing their application and discussing the latest advances.
Similar articles
-
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.Biomaterials. 2013 May;34(14):3647-57. doi: 10.1016/j.biomaterials.2013.01.084. Epub 2013 Feb 14. Biomaterials. 2013. PMID: 23415642 Review.
-
Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.Int J Nanomedicine. 2016 Dec 8;11:6591-6608. doi: 10.2147/IJN.S120611. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27994460 Free PMC article.
-
Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery.Biomater Sci. 2018 May 29;6(6):1457-1468. doi: 10.1039/c8bm00226f. Biomater Sci. 2018. PMID: 29770812
-
Polycation-based nanoparticle delivery for improved RNA interference therapeutics.Expert Opin Biol Ther. 2007 Dec;7(12):1811-22. doi: 10.1517/14712598.7.12.1811. Expert Opin Biol Ther. 2007. PMID: 18034647 Review.
-
Smart stimuli-responsive drug delivery systems based on cyclodextrin: A review.Carbohydr Polym. 2021 Jan 1;251:116871. doi: 10.1016/j.carbpol.2020.116871. Epub 2020 Aug 10. Carbohydr Polym. 2021. PMID: 33142550 Review.
Cited by
-
Trigger-Responsive Gene Transporters for Anticancer Therapy.Nanomaterials (Basel). 2017 May 26;7(6):120. doi: 10.3390/nano7060120. Nanomaterials (Basel). 2017. PMID: 28587119 Free PMC article. Review.
-
Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models.Nanomedicine (Lond). 2016 Apr;11(7):767-81. doi: 10.2217/nnm.16.14. Epub 2016 Mar 16. Nanomedicine (Lond). 2016. PMID: 26980454 Free PMC article.
-
RNA Nanotechnology-Mediated Cancer Immunotherapy.Theranostics. 2020 Jan 1;10(1):281-299. doi: 10.7150/thno.35568. eCollection 2020. Theranostics. 2020. PMID: 31903120 Free PMC article. Review.
-
Evaluating Nanoshells and a Potent Biladiene Photosensitizer for Dual Photothermal and Photodynamic Therapy of Triple Negative Breast Cancer Cells.Nanomaterials (Basel). 2018 Aug 25;8(9):658. doi: 10.3390/nano8090658. Nanomaterials (Basel). 2018. PMID: 30149630 Free PMC article.
-
Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jul;9(4):10.1002/wnan.1449. doi: 10.1002/wnan.1449. Epub 2017 Feb 3. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017. PMID: 28160445 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources